Madécassol (Centella Asiatica Extract)

Centella Asiatica delivers triterpenoid saponins like asiaticoside and madecassoside. These compounds stimulate fibroblast activity, increase collagen production, promote new blood‑vessel formation, and modulate inflammatory pathways, thereby enhancing tissue repair and reducing scar formation when applied to the skin.

The appropriate amount of Madécassol is determined by the prescribing healthcare professional based on the specific skin condition, area to be treated, and patient factors. No fixed dosing regimen is provided here; the prescriber will give individualized instructions.

Safety data for Madécassol in pregnancy and lactation are limited. It is recommended that pregnant or breastfeeding individuals consult their physician before using the product, and it should generally be avoided unless the potential benefit outweighs any possible risk.

To order Madécassol, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Compared with synthetic wound‑healing agents, Madécassol offers a botanical alternative that targets collagen synthesis and inflammation through natural saponins. While synthetic products may provide faster closure in some cases, Madécassol is valued for its biocompatibility, lower risk of systemic toxicity, and additional benefits for scar remodeling.

Madécassol should be stored at room temperature, ideally below 25 °C, in its original packaging. Keep the container tightly closed, protect it from direct sunlight, moisture, and extreme temperature fluctuations to maintain product stability.

Madécassol is applied topically to clean, dry skin. A thin layer is spread over the affected area once or twice daily, or as directed by the healthcare provider. Gentle massage may aid absorption, and the treated area should be covered only if advised.

The most serious risks include severe allergic reactions such as anaphylaxis, extensive dermatitis, or rare conditions like Stevens‑Johnson syndrome. Users should discontinue the product and seek immediate medical attention if they experience swelling, widespread rash, blistering, or systemic symptoms such as fever.

Individuals with a known hypersensitivity to Centella Asiatica or any component of the formulation should avoid using Madécassol. It is also contraindicated in patients who are pregnant or breastfeeding without medical advice, and in those using conflicting topical therapies without professional supervision.